IntrinsicIntrinsic
← Scroll for more →

Financial Statements — MLYS

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023
Cash & Equivalents138.27112.78172.92217.60101.79165.01114.0997.2767.8690.4249.3086.30101.14138.25
Total Current Assets665.80652.47661.39599.80335.27354.51205.35267.73318.00346.82249.10265.38269.49275.27
Property, Plant & Equipment0.030.030.040.010.020.040.050.070.040.05--------
Total Non-current Assets*2.050.390.420.150.460.440.550.520.490.432.5312.1821.7331.16
Total Assets667.85652.86661.81599.95335.72354.94205.90268.25318.49347.25251.64277.56291.22306.44
Accounts Payable1.071.122.021.123.160.370.483.111.714.260.605.572.202.39
Total Current Liabilities19.3214.7215.1123.5222.1713.3914.6531.3228.4019.2010.4813.546.2110.56
Long-term Debt0.10--------------------------
Total Non-current Liabilities*97.620.000.000.000.000.000.000.000.000.000.000.000.000.00
Total Liabilities*116.9414.7215.1123.5222.1713.3914.6531.3228.4019.2010.4813.546.2110.56
Retained Earnings(737.58)(496.51)(457.17)(424.93)(388.00)(344.73)(302.52)(253.57)(197.23)(156.22)(124.71)(100.32)(77.56)(65.42)
Total Stockholder Equity550.92638.14646.69576.43313.55341.56191.26236.93290.10328.05241.15264.01285.01295.88
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023
Research & Development221.3824.3724.4031.4538.2837.8844.5753.9939.2730.7523.6922.5011.8812.29
Selling, General & Admin24.6620.9813.889.688.476.577.206.125.904.614.033.773.852.65
Total Operating Expenses246.0445.3438.2841.1346.7544.4551.7760.1145.1735.3627.7126.2715.7414.94
Operating Income(246.04)(45.34)(38.28)(41.13)(46.75)(44.45)(51.77)(60.11)(45.17)(35.36)(27.71)(26.27)(15.73)(14.94)
Pretax Income*------(36.93)--------------------
Tax Provision------0.00--------------------
Net Income(241.07)(39.34)(32.23)(36.93)(43.27)(42.21)(48.95)(56.34)(41.01)(31.51)(24.39)(22.76)(12.14)(12.61)
Basic EPS(2.85)(0.47)(0.32)(0.52)(0.66)(0.79)(1.00)(1.13)(0.83)(0.70)(0.60)(0.57)(0.31)(0.51)
Diluted EPS(2.85)(0.47)(0.32)(0.52)(0.66)(0.79)(1.00)(1.13)(0.83)(0.70)(0.60)(0.57)(0.31)(0.51)
← Scroll for more columns →

* Derived from reported values

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023
Operating Cash Flow(32.56)(39.47)(37.89)(28.87)(30.17)(45.49)(66.84)(50.19)(30.15)(19.14)(28.98)(19.03)(20.39)(12.77)
Capital Expenditures----0.020.000.000.000.000.040.000.06--------
Free Cash Flow*----(37.90)(28.87)(30.17)(45.49)(66.84)(50.22)(30.15)(19.20)--------
Investing Cash Flow(185.22)(44.94)(103.49)(150.51)(42.88)(92.88)83.5779.617.74(55.95)(8.09)4.01(16.14)(140.25)
Financing Cash Flow243.2624.2796.70295.199.83189.280.09-0.00(0.15)116.210.070.18(0.58)203.57
← Scroll for more columns →

* Derived from reported values